New Strong Sell Stocks for March 14th

Business Wire
Promega Contributes to New Study on Reversible, Non-Hormonal Male Contraception
MADISON, Wis., June 04, 2024--New research published in Science describes a reversible, non-hormonal contraceptive strategy in mice.
Business Wire
Back by Popular Demand: HEINZ to Drop Limited-Edition Black Garlic Ranch and Harissa Aioli Sauces in Stores Nationwide
PITTSBURGH & CHICAGO, June 04, 2024--Today, the HEINZ brand drops two limited-edition, new-to-category sauces: Black Garlic Ranch and Harissa Aioli, now rolling out exclusively to Walmart and Target stores nationwide. After testing six sauces in select restaurants last year, HEINZ is bringing two fan-favorite flavors to store shelves – giving people across the country a chance to try them for the first time. The launch of Black Garlic Ranch and Harissa Aioli marks the first innovations HEINZ has
Moneywise
There is no ‘magic’ number for your 401(k) — here’s what you should focus on instead for a comfy retirement
Many Americans think they’ll need $1.46 million to retire.
Business Wire
Rapid Finance Enhances Lynx Platform with Cloud-Based Rules Engine to Enhance SMB Lending
BETHESDA, Md., June 04, 2024--Rapid Finance, a leading small business banking platform specializing in providing customized financing solutions, announced today the availability of its cloud-based rules engine as part of its recently enhanced, award-winning AI fraud detection platform, Lynx. The updated rules engine enables Rapid Finance’s enterprise customers to create customized risk management rules and outcomes, further strengthening the ability to make informed lending decisions tailored to
Yahoo Sports Videos
Krysten Peek’s NBA Mock Draft 8.0
Yahoo Sports NBA draft analyst Krysten Peek runs through her latest top five in her mock of this month's draft, highlighted by a prospect’s long ascension to the top spot.
USA TODAY
How do I break into finance and stay competitive? Ask HR
Here are 7 tips to help start your career in finance and build your skills to enhance it.
Business Wire
GlycoMimetics Announces Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
ROCKVILLE, Md., June 04, 2024--GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced comprehensive results from the company’s pivotal Phase 3 study of uproleselan in R/R AML.
Business Wire
BioTalent Canada Celebrates Five Years of Being Certified as a Great Place to Work®
OTTAWA, Ontario, June 04, 2024--For the fifth consecutive year, BioTalent Canada has been honoured with the distinction of being certified as a Great Place to Work®. This recognition is a testament to the hard work and enthusiasm of a team dedicated to creating a strong and resilient bio-economy in Canada.
GlobeNewswire
Dr. Pumla Gobodo-Madikizela Receives 2024 Templeton Prize
She Joins Past Laureates Desmond Tutu and Jane Goodall to Receive One of the World’s Largest Individual Lifetime Achievement Awards 2024 Templeton Prize Winner Pumla Gobodo-Madikizela 2024 Templeton Prize Winner Pumla Gobodo-Madikizela photographed in Cape Town, South Africa by Stefan Els for the Templeton Prize 2024 Templeton Prize Winner Pumla Gobodo-Madikizela 2024 Templeton Prize Winner Pumla Gobodo-Madikizela photographed in Cape Town, South Africa by Stefan Els for the Templeton Prize West
GlobeNewswire
DISQO Welcomes Neil Graham as Chief Revenue Officer
Graham to lead DISQO’s growth efforts, helping businesses better understand their audiences and measure the full brand experienceLOS ANGELES, June 04, 2024 (GLOBE NEWSWIRE) -- DISQO announced today the appointment of Neil Graham as its Chief Revenue Officer. Leveraging over 25 years of strategic revenue and sales management experience, Graham will lead DISQO’s Sales teams as the company scales its brand experience platform. As CRO, Graham will focus on DISQO’s overall business growth; spearheadi
GlobeNewswire
Augmedix Reiterates Second Quarter and Full Year 2024 Outlook
Management Provides Update in Advance of William Blair Annual Growth Stock Conference AppearanceSAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reiterated its expectations in advance of management’s participation at the William Blair Annual Growth Stock Conference. Management continues to expect second quarter 2024 revenue to increase slightly sequentially from the first quarter of 2024, and second q
Business Wire
Dexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 Diabetes
EDINBURGH, Scotland, June 04, 2024--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in access to its products for those treating Type 2 diabetes (T2D) with basal insulin injections. The company, which pioneered CGM technology 25 years ago, has secured access to its Dexcom ONE sensor for around 100,000 T2D users in France. The reimbursement guidance offers people aged over two years who are
Business Wire
Allegion Acquires Krieger Specialty Products, Expanding Allegion Americas Institutional Market Portfolio
DUBLIN, June 04, 2024--Allegion plc (NYSE: ALLE), a leading global security products and solutions provider, through one of its subsidiaries, has acquired Krieger Specialty Products LLC ("Krieger").
Business Wire
NCC and PeptiDream Announce the First Dosing of 64Cu-PD-32766 in a patient with Clear Cell Renal Cell Carcinoma
KAWASAKI, Japan, June 04, 2024--National Cancer Center and PeptiDream Inc.:
GlobeNewswire
Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
DURHAM, N.C., June 04, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) a leading global contract research organization (“CRO”), today announced it has completed the divestiture of assets relating to its Enabling Services segment, namely its Endpoint Clinical (“Endpoint”) and Fortrea Patient Access (“FPA”) businesses, to Arsenal Capital Partners (“Arsenal”), a leading private equity firm specializing in building market-leading, technology-rich healthcare and industrial growth companies. Endpoint
GlobeNewswire
5E Advanced Materials Provides Organizational Update
New director appointments and leadership changes strengthen the Company as it shifts strategic focus towards Phase 1 of commercial operationsHESPERIA, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”), a boron and lithium company with U.S. government Critical Infrastructure designation for its 5E Boron Americas Complex, today provided a business update regarding its executive leadership and organizational structure. Effective
GlobeNewswire
Bunker Hill Exploration From Discovery to Delivery
TORONTO, June 04, 2024 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSXV: BNKR, OTCQB: BHLL) is pleased to provide an update on its recently commenced underground exploration program at the Bunker Hill Mine located in Kellogg, Idaho. The Company’s 1300-acre land package consists of patented claims and represents the largest single claim package within Northern Idaho’s prolific Silver Valley. This exploration is being conducted concurrent with the ongoing constru
GlobeNewswire
Brunswick Exploration Drills 69.3 Meters at 1.64% Li2o at Mr-6
MONTREAL, June 04, 2024 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; “BRW” or the “Company”) is pleased to report the final results from the Mirage winter drilling campaign. The Mirage Project is located in the Eeyou Istchee-James Bay region of Quebec, approximately 40 kilometres south of the Trans-Taiga Road. The winter drill campaign focused on the Central Zone and has continued to intersect wide and well mineralized intervals within the MR-6 dyke. Highlights inclu
Business Wire
More Than 75% of U.S. Companies Cite Climate Change as a Material Risk, According to Diligent
NEW YORK, June 04, 2024--In 2023, 76.2% of the 3000 largest U.S. companies mentioned climate change as a risk in their annual financial reports, up from 68.2% a year prior. This is according to the new Diligent Market Intelligence: ESG Engagements in 2024 report from Diligent.
Business Wire
Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)
SOUTH SAN FRANCISCO, Calif. & MUNICH, June 04, 2024--Spruce Biosciences, Inc. (Nasdaq: SPRB) ("Spruce"), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant unmet medical need, and HMNC Brain Health GmbH ("HMNC"), a global precision psychiatry biopharma company, announced today a strategic collaboration to develop Spruce’s investigational product candidate, tildacerfont, a second-generation CRF

NZX 50

NZD/USD

ALL ORDS

OIL

GOLD

New Strong Sell Stocks for March 14th

Latest stories

Promega Contributes to New Study on Reversible, Non-Hormonal Male Contraception

Back by Popular Demand: HEINZ to Drop Limited-Edition Black Garlic Ranch and Harissa Aioli Sauces in Stores Nationwide

There is no ‘magic’ number for your 401(k) — here’s what you should focus on instead for a comfy retirement

Rapid Finance Enhances Lynx Platform with Cloud-Based Rules Engine to Enhance SMB Lending

Krysten Peek’s NBA Mock Draft 8.0

How do I break into finance and stay competitive? Ask HR

GlycoMimetics Announces Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

BioTalent Canada Celebrates Five Years of Being Certified as a Great Place to Work®

Dr. Pumla Gobodo-Madikizela Receives 2024 Templeton Prize

DISQO Welcomes Neil Graham as Chief Revenue Officer

Augmedix Reiterates Second Quarter and Full Year 2024 Outlook

Dexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 Diabetes

Allegion Acquires Krieger Specialty Products, Expanding Allegion Americas Institutional Market Portfolio

NCC and PeptiDream Announce the First Dosing of 64Cu-PD-32766 in a patient with Clear Cell Renal Cell Carcinoma

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

5E Advanced Materials Provides Organizational Update

Bunker Hill Exploration From Discovery to Delivery

Brunswick Exploration Drills 69.3 Meters at 1.64% Li2o at Mr-6

More Than 75% of U.S. Companies Cite Climate Change as a Material Risk, According to Diligent

Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)